Volume 16, Issue 11 pp. 1176-1178

Continuous venovenous hemodiafiltration to treat controlled-release carbamazepine overdose in a pediatric patient

TULAY SAHIN YILDIZ MD

TULAY SAHIN YILDIZ MD

Department of Anaesthesiology, School of Medicine, University of Kocaeli, Kocaeli, Turkey

Search for more papers by this author
DEMET GEDIKBASI TOPRAK MD

DEMET GEDIKBASI TOPRAK MD

Department of Pediatrics, School of Medicine, University of Kocaeli, Kocaeli, Turkey

Search for more papers by this author
EMIN SAMI ARISOY MD

EMIN SAMI ARISOY MD

Department of Pediatrics, School of Medicine, University of Kocaeli, Kocaeli, Turkey

Search for more papers by this author
MINE SOLAK MD

MINE SOLAK MD

Department of Anaesthesiology, School of Medicine, University of Kocaeli, Kocaeli, Turkey

Search for more papers by this author
KAMIL TOKER MD

KAMIL TOKER MD

Department of Anaesthesiology, School of Medicine, University of Kocaeli, Kocaeli, Turkey

Search for more papers by this author
First published: 14 August 2006
Citations: 18
Tulay Sahin Yildiz, PK: 17, Derince, 41900, Kocaeli, Turkey (email: [email protected]; [email protected]).

Summary

Carbamazepine (CBZ) intoxication is an important issue in acute poisoning practice. Highly protein-bound, CBZ is not removed efficiently through conventional hemodialysis. We describe the use of continuous venovenous hemodiafiltration (CVVHDF) in a 2-year-old boy who developed general tonic clonic seizure and respiratory depression due to controlled-release formula of CBZ overdose (peak drug level of >20 μg·ml−1, therapeutic range: 5–10 μg·ml−1). Serum CBZ concentrations fell to 0.25 μg·ml−1 at the end of hemodiafiltration. The patient recovered rapidly and was discharged from hospital 4 days from the time of ingestion with no complications or neurologic impairment.

The full text of this article hosted at iucr.org is unavailable due to technical difficulties.